Sculati Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Sell |
754
-714
| -49% | -$375K | 0.15% | 93 |
|
|
2025
Q1 | $931K | Sell |
1,468
-485
| -25% | -$308K | 0.38% | 60 |
|
|
2024
Q4 | $1.39M | Sell |
1,953
-38
| -2% | -$27.1K | 0.55% | 49 |
|
|
2024
Q3 | $2.09M | Sell |
1,991
-18
| -0.9% | -$18.9K | 0.83% | 37 |
|
|
2024
Q2 | $2.11M | Sell |
2,009
-38
| -2% | -$39.9K | 0.9% | 41 |
|
|
2024
Q1 | $1.97M | Buy |
2,047
+15
| +0.7% | +$14.4K | 0.85% | 38 |
|
|
2023
Q4 | $1.78M | Hold |
2,032
| – | – | 0.83% | 40 |
|
|
2023
Q3 | $1.67M | Sell |
2,032
-112
| -5% | -$92.2K | 0.85% | 41 |
|
|
2023
Q2 | $1.54M | Sell |
2,144
-42
| -2% | -$30.2K | 0.78% | 44 |
|
|
2023
Q1 | $1.8M | Sell |
2,186
-13
| -0.6% | -$10.7K | 0.95% | 34 |
|
|
2022
Q4 | $1.59M | Hold |
2,199
| – | – | 0.89% | 35 |
|
|
2022
Q3 | $1.52M | Sell |
2,199
-10
| -0.5% | -$6.89K | 0.89% | 37 |
|
|
2022
Q2 | $1.31M | Sell |
2,209
-99
| -4% | -$58.5K | 0.75% | 51 |
|
|
2022
Q1 | $1.61M | Buy |
2,308
+110
| +5% | +$76.8K | 0.79% | 44 |
|
|
2021
Q4 | $1.39M | Buy |
2,198
+131
| +6% | +$82.7K | 0.67% | 46 |
|
|
2021
Q3 | $1.25M | Buy |
2,067
+105
| +5% | +$63.5K | 0.66% | 47 |
|
|
2021
Q2 | $1.1M | Buy |
1,962
+138
| +8% | +$77.1K | 0.58% | 53 |
|
|
2021
Q1 | $863K | Buy |
1,824
+553
| +44% | +$262K | 0.5% | 59 |
|
|
2020
Q4 | $614K | Buy |
1,271
+30
| +2% | +$14.5K | 0.4% | 62 |
|
|
2020
Q3 | $695K | Buy |
1,241
+308
| +33% | +$172K | 0.52% | 49 |
|
|
2020
Q2 | $582K | Buy |
+933
| New | +$582K | 0.49% | 55 |
|